Literature DB >> 22828779

Tick-borne encephalitis virus in Eastern Siberia: complete genome characteristics.

Nina V Kulakova1, Evgenii I Andaev, Sergei I Belikov.   

Abstract

Tick-borne encephalitis (TBE) is one of the most important arboviral diseases across Eurasia. TBE virus (TBEV) is transmitted by tick bite and causes a potentially fatal neurological infection in humans. In the Russian Federation, TBE is endemic in most regions, with 3000-5000 cases of the disease annually. To characterise TBEV in Eastern Siberia, the complete genomes of five TBEV isolates from patients with different clinical manifestations were sequenced. The results show that the Siberian and Far Eastern subtypes of TBEV cause the disease in people in Eastern Siberia. Complete genome analysis revealed an unexpectedly high genetic variability within the Siberian subtype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22828779     DOI: 10.1007/s00705-012-1412-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  Complete Genome Sequencing of Tick-Borne Encephalitis Virus Directly from Clinical Samples: Comparison of Shotgun Metagenomic and Targeted Amplicon-Based Sequencing.

Authors:  Samo Zakotnik; Nataša Knap; Petra Bogovič; Tomaž Mark Zorec; Mario Poljak; Franc Strle; Tatjana Avšič-Županc; Miša Korva
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

2.  Tick-borne encephalitis cases recorded in Ukraine over 1990-2018.

Authors:  Oksana O Yurchenko; Dmytro O Dubyna; Nataliya O Vynograd; Artem S Rogovskyy
Journal:  J Travel Med       Date:  2020-07-14       Impact factor: 8.490

3.  The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.

Authors:  Richard Lindqvist; Ebba Rosendal; Elvira Weber; Naveed Asghar; Sarah Schreier; Annasara Lenman; Magnus Johansson; Gerhard Dobler; Malena Bestehorn; Andrea Kröger; Anna K Överby
Journal:  J Neuroinflammation       Date:  2020-09-28       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.